Adma Biologics (ADMA) Research & Development (2011 - 2025)
Adma Biologics (ADMA) posted Research & Development of $1.4 million for Q4 2025, down 9.95% on a QoQ basis from $1.5 million in Q3 2025, and up 251.92% year-over-year from $391000.0 in Q4 2024.
Adma Biologics (ADMA) Research & Development (2011 - 2025) Analysis & Trends
Adma Biologics' Research & Development history runs 13 years deep, the most recent figure standing at $1.4 million for Q4 2025.
- Quarterly Research & Development rose 251.92% year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.8 million (up 162.6% YoY) and the FY2025 annual result came in at $4.8 million, up 162.66% from the prior year.
- Research & Development was $1.4 million for Q4 2025 at Adma Biologics, down from $1.5 million in the prior quarter.
- Across five years, Research & Development topped out at $1.5 million in Q3 2025 and bottomed at $391000.0 in Q4 2024.
- A 5-year average of $856700.0 and a median of $840500.0 in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2024 — Research & Development plunged 60.09% — and 2025, when it soared 270.87%.
- Adma Biologics' Research & Development stood at $728928.0 in 2021, then soared by 47.42% to $1.1 million in 2022, then sank by 58.49% to $446000.0 in 2023, then retreated by 12.33% to $391000.0 in 2024, then soared by 251.92% to $1.4 million in 2025.
- Business Quant data shows ADMA's Research & Development at $1.4 million in Q4 2025, $1.5 million in Q3 2025, and $1.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.38 Mn |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 826,000.00 |
| Dec 31, 2024 | 391,000.00 |
| Sep 30, 2024 | 412,000.00 |
| Jun 30, 2024 | 560,000.00 |
| Mar 31, 2024 | 450,000.00 |
| Dec 31, 2023 | 446,000.00 |
| Sep 30, 2023 | 596,000.00 |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 855,000.00 |
| Dec 31, 2022 | 1.07 Mn |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 873,386.00 |
| Mar 31, 2022 | 624,111.00 |
| Dec 31, 2021 | 728,928.00 |
| Sep 30, 2021 | 770,557.00 |
| Jun 30, 2021 | 1.16 Mn |
| Mar 31, 2021 | 987,649.00 |